PortfoliosLab logoPortfoliosLab logo
RGC vs. YUMC
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

RGC vs. YUMC - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Regencell Bioscience Holdings Limited (RGC) and Yum China Holdings, Inc. (YUMC). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, RGC achieves a 13.10% return, which is significantly higher than YUMC's -8.96% return.


RGC

1D
2.59%
1M
-13.19%
YTD
13.10%
6M
82.55%
1Y
48.17%
3Y*
242.31%
5Y*
10Y*

YUMC

1D
-1.04%
1M
-9.65%
YTD
-8.96%
6M
-7.99%
1Y
1.21%
3Y*
-8.17%
5Y*
-7.48%
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

RGC vs. YUMC - Yearly Performance Comparison


2026 (YTD)20252024202320222021
RGC
Regencell Bioscience Holdings Limited
13.10%16,053.85%-52.95%-62.35%-12.43%203.33%
YUMC
Yum China Holdings, Inc.
-8.96%1.18%15.41%-21.60%10.75%-22.64%

Correlation

The correlation between RGC and YUMC is -0.08, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

-0.08

Correlation (3Y)
Calculated over the trailing 3-year period

-0.00

Correlation (All Time)
Calculated using the full available price history since Jul 19, 2021

0.06

The correlation between RGC and YUMC shifts across timeframes, from -0.08 (1 year) to 0.06 (all time), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap

RGC:

$11.74B

YUMC:

$15.16B

EPS

RGC:

-$0.02

YUMC:

$2.60

PB Ratio

RGC:

9.63K

YUMC:

2.79

Total Revenue (TTM)

RGC:

$0.00

YUMC:

$12.09B

Gross Profit (TTM)

RGC:

-$40.84K

YUMC:

$1.47B

EBITDA (TTM)

RGC:

-$8.81M

YUMC:

$1.71B

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

RGC vs. YUMC — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

RGC
RGC Risk / Return Rank: 6565
Overall Rank
RGC Sharpe Ratio Rank: 4545
Sharpe Ratio Rank
RGC Sortino Ratio Rank: 9191
Sortino Ratio Rank
RGC Omega Ratio Rank: 9090
Omega Ratio Rank
RGC Calmar Ratio Rank: 5353
Calmar Ratio Rank
RGC Martin Ratio Rank: 4747
Martin Ratio Rank

YUMC
YUMC Risk / Return Rank: 3939
Overall Rank
YUMC Sharpe Ratio Rank: 4242
Sharpe Ratio Rank
YUMC Sortino Ratio Rank: 3636
Sortino Ratio Rank
YUMC Omega Ratio Rank: 3535
Omega Ratio Rank
YUMC Calmar Ratio Rank: 4141
Calmar Ratio Rank
YUMC Martin Ratio Rank: 4141
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

RGC vs. YUMC - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Regencell Bioscience Holdings Limited (RGC) and Yum China Holdings, Inc. (YUMC). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


RGCYUMCDifference

Sharpe ratio

Return per unit of total volatility

0.14

0.05

+0.09

Sortino ratio

Return per unit of downside risk

3.42

0.26

+3.17

Omega ratio

Gain probability vs. loss probability

1.44

1.03

+0.41

Calmar ratio

Return relative to maximum drawdown

0.56

0.05

+0.51

Martin ratio

Return relative to average drawdown

0.67

0.12

+0.55

RGC vs. YUMC - Sharpe Ratio Comparison

The current RGC Sharpe Ratio is 0.14, which is higher than the YUMC Sharpe Ratio of 0.05. The chart below compares the historical Sharpe Ratios of RGC and YUMC, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


RGCYUMCDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

0.14

0.05

+0.09

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

-0.20

Sharpe Ratio (All Time)

Calculated using the full available price history

0.49

0.19

+0.30

Drawdowns

RGC vs. YUMC - Drawdown Comparison

The maximum RGC drawdown since its inception was -93.09%, which is greater than YUMC's maximum drawdown of -56.49%. Use the drawdown chart below to compare losses from any high point for RGC and YUMC.


Loading charts...

Drawdown Indicators


RGCYUMCDifference

Max Drawdown

Largest peak-to-trough decline

-93.09%

-56.49%

-36.60%

Max Drawdown (1Y)

Largest decline over 1 year

-86.72%

-25.89%

-60.83%

Max Drawdown (3Y)

Largest decline over 3 years

-88.34%

-51.42%

-36.92%

Max Drawdown (5Y)

Largest decline over 5 years

-56.45%

Current Drawdown

Current decline from peak

-69.55%

-33.43%

-36.12%

Average Drawdown

Average peak-to-trough decline

-59.29%

-19.34%

-39.95%

Ulcer Index

Depth and duration of drawdowns from previous peaks

71.76%

9.97%

+61.79%

Volatility

RGC vs. YUMC - Volatility Comparison

Regencell Bioscience Holdings Limited (RGC) has a higher volatility of 21.55% compared to Yum China Holdings, Inc. (YUMC) at 5.45%. This indicates that RGC's price experiences larger fluctuations and is considered to be riskier than YUMC based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


RGCYUMCDifference

Volatility (1M)

Calculated over the trailing 1-month period

21.55%

5.45%

+16.10%

Volatility (6M)

Calculated over the trailing 6-month period

110.23%

18.91%

+91.32%

Volatility (1Y)

Calculated over the trailing 1-year period

344.85%

25.41%

+319.44%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

308.92%

37.20%

+271.72%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

308.92%

35.41%

+273.51%

Dividends

RGC vs. YUMC - Dividend Comparison

RGC has not paid dividends to shareholders, while YUMC's dividend yield for the trailing twelve months is around 2.47%.


PositionTTM202520242023202220212020201920182017
RGC
Regencell Bioscience Holdings Limited
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
YUMC
Yum China Holdings, Inc.
2.47%2.01%1.33%1.23%0.88%0.96%0.42%1.00%1.25%0.25%

Financials

RGC vs. YUMC - Financials Comparison

This section allows you to compare key financial metrics between Regencell Bioscience Holdings Limited and Yum China Holdings, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


-2.00B-1.00B0.001.00B2.00B3.00B2021202220232024202520260
3.27B
(RGC) Total Revenue
(YUMC) Total Revenue
Values in USD except per share items

Frequently Asked Questions


RGC and YUMC have a correlation of -0.08, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

RGC has higher volatility (21.55%) compared to YUMC (5.45%). In terms of maximum drawdown, RGC dropped -93.09% vs YUMC's -56.49%.

RGC currently has the higher Sharpe Ratio (0.14 vs 0.05), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for RGC and YUMC

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer